Buclizine

Buclizine is an antihistamine and anticholinergic of the diphenylmethylpiperazine group. It is considered to be an antiemetic, similar to meclizine.[1]

Buclizine

Clinical data
AHFS/Drugs.com	Micromedex Detailed Consumer Information
ATC code	R06AE01 (WHO)
Identifiers
IUPAC name (RS)-1-[(4-chlorophenyl)- phenyl-methyl]-4- [(4-tert-butylphenyl) methyl] piperazine
CAS Number	82-95-1^Y
PubChem CID	6729
IUPHAR/BPS	7134
DrugBank	DB00354^Y
ChemSpider	6473^Y
UNII	0C94V6X681
ChEBI	CHEBI:3205^Y
ChEMBL	ChEMBL1201271^N
CompTox Dashboard (EPA)	DTXSID0022694
ECHA InfoCard	100.001.317
Chemical and physical data
Formula	C28H33ClN2
Molar mass	433.04 g·mol^−1
3D model (JSmol)	Interactive image
Chirality	Racemic mixture
SMILES Clc1ccc(cc1)C(c2ccccc2)N3CCN(CC3)Cc4ccc(cc4)C(C)(C)C
InChI InChI=1S/C28H33ClN2/c1-28(2,3)25-13-9-22(10-14-25)21-30-17-19-31(20-18-30)27(23-7-5-4-6-8-23)24-11-15-26(29)16-12-24/h4-16,27H,17-21H2,1-3H3^Y Key:MOYGZHXDRJNJEP-UHFFFAOYSA-N^Y
^NY (what is this?)  (verify)

In the United Kingdom, buclizine is one of three drugs contained in Migraleve tablets, marketed by McNeil Healthcare at migraine sufferers.[2]

References

1. Mostafa GA, Al-Badr AA (2011). "Buclizine". Profiles Drug Subst Excip Relat Methodol. Profiles of Drug Substances, Excipients and Related Methodology. 36: 1–33. doi:10.1016/B978-0-12-387667-6.00001-4. ISBN 9780123876676. PMID 22469258.
2. Behrendt WA, Cserepes J (1985). "Acute toxicity and analgesic action of a combination of buclizine, codeine and paracetamol ('Migraleve') in tablet and suppository form in rats". Pharmatherapeutica. 4 (5): 322–31. PMID 4070325.